BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Radiance has been selected to Present at the 2025 Biotech Showcase™ Alongside the J.P. Morgan Healthcare Conference

  January 16, 2025

   · 

  1 min read
• Press Releases

  Mainstay Medical Announces Positive Outcomes from Landmark RESTORE Clinical Trial of ReActiv8®

  January 16, 2025

   · 

  7 min read
• Press Releases

  Idorsia presents at J.P. Morgan Healthcare Conference 2025 – fighting to create value for all stakeholders

  January 16, 2025

   · 

  10 min read
• 

  Business

  A Conversation with Peter Marks: Insights into GenScript Biotech Forum 2025

  In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis talks to Dr. Peter Marks, Director, CBER about his thoughts on the future of cell and gene therapies.

  January 16, 2025

   · 

  1 min read

   · 

  Lori Ellis
• Press Releases

  Santhera Pharmaceuticals Provides Update on Royalty Agreement for AGAMREE® (Vamorolone) and Warrants held by Idorsia

  January 16, 2025

   · 

  6 min read
• Press Releases

  Santhera Receives Positive NICE Final Guidance for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy

  January 16, 2025

   · 

  4 min read
• Press Releases

  Actimed Therapeutics appoints Dr Fabio Dorigotti as Chief Medical Officer to drive further pipeline development for cancer cachexia and other muscle wasting disorders

  January 16, 2025

   · 

  3 min read
• Press Releases

  BioWorld by Clarivate Releases Comprehensive 2024 Year in Review

  January 16, 2025

   · 

  6 min read
• Press Releases

  Enigma Biomedical USA and the University of Wisconsin–Madison announce Formation of a Partnership to Advance Development of Next-Generation Imaging and Fluid Biomarkers for Improved Understanding and Management of Neurodegenerative Diseases

  January 16, 2025

   · 

  3 min read
• 

  Pipeline

  BioNTech Strives to Become Commercial ‘Powerhouse’ While Maintaining Humility

  Annemarie Hanekamp has overseen some of the most transformative changes in oncology over her years in Big Pharma. Now, she will oversee BioNTech’s transition from a COVID-19 vaccine maker to an “end-to-end organizational oncology powerhouse.”

  January 16, 2025

   · 

  4 min read

   · 

  Annalee Armstrong